Ablative Therapies for Colorectal Liver Metastases

Surgical Oncology Clinics of North America

Volumn 20, Issue 2, 2011, Pages 259-271

  Brown, Russell E ^a   Martin, Robert C G ^a   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Ablative therapies; Chemotherapy; Colorectal adenocarcinoma; Liver metastases

Indexed keywords

ADENOCARCINOMA; ADVERSE OUTCOME; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CARCINOMA; CRYOABLATION; ELECTROPORATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LASER THERMOTHERAPY; LIVER METASTASIS; LIVER RESECTION; MICROWAVE THERAPY; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY; TEMPERATURE SENSITIVITY; THERAPY EFFECT; TUMOR VOLUME;

ABLATION TECHNIQUES; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 79952129831     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.11.005     Document Type: Review

References (80)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
2. Steele G., Ravikumar T.S. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989, 210(2):127-138.
3. Scheele J., Stangl R., Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990, 77(11):1241-1246.
4. Lewis A.M., Martin R.C. The treatment of hepatic metastases in colorectal carcinoma. Am Surg 2006, 72(6):466-473.
5. Parikh A.A., Curley S.A., Fornage B.D., et al. Radiofrequency ablation of hepatic metastases. Semin Oncol 2002, 29(2):168-182.
6. Tomlinson J.S., Jarnagin W.R., DeMatteo R.P., et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007, 25(29):4575-4580.
7. Timmerman R.D., Bizekis C.S., Pass H.I., et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009, 59(3):145-170.
8. Hellman S., Weichselbaum R.R. Oligometastases. J Clin Oncol 1995, 13(1):8-10.
9. Norton L., Simon R. The Norton-Simon hypothesis revisited. Cancer Treat Rep 1986, 70(1):163-169.
10. Simon R., Norton L. The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens. Nat Clin Pract Oncol 2006, 3(8):406-407.
11. Cooper I.S., Hirose T. Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med 1966, 274(1):15-18.
12. Wemyss-Holden S.A., Dennison A.R., Berry D.P., et al. Local ablation for unresectable liver tumors: is thermal best?. J Hepatobiliary Pancreat Surg 2004, 11(2):97-106.
13. Onik G., Rubinsky B., Zemel R., et al. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer 1991, 67(4):901-907.
14. Goodie D.B., Horton M.D., Morris R.W., et al. Anaesthetic experience with cryotherapy for treatment of hepatic malignancy. Anaesth Intensive Care 1992, 20(4):491-496.
15. Seifert J.K., Morris D.L. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999, 23(2):109-113. [discussion: 113-4].
16. Rodriguez-Bigas M.A., Klippenstein D., Meropol N.J., et al. A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer. Cryobiology 1996, 33(6):600-606.
17. Mayo S.C., Pawlik T.M. Thermal ablative therapies for secondary hepatic malignancies. Cancer J 2010, 16(2):111-117.
18. Adam R., Akpinar E., Johann M., et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997, 225(1):39-48. [discussion: 48-50].
19. Adam R., Hagopian E.J., Linhares M., et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002, 137(12):1332-1339. [discussion: 1340].
20. Pearson A.S., Izzo F., Fleming R.Y., et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999, 178(6):592-599.
21. Curley S.A. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003, 10(4):338-347.
22. Steeves R.A. Hyperthermia in cancer therapy: where are we today and where are we going?. Bull N Y Acad Med 1992, 68(2):341-350.
23. Bischof J., Christov K., Rubinsky B. A morphological study of cooling rate response in normal and neoplastic human liver tissue: cryosurgical implications. Cryobiology 1993, 30(5):482-492.
24. Leveen R.F. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Interv Radiol 1997, 14:313-324.
25. Dickson J.A., Calderwood S.K. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci 1980, 335:180-205.
26. Nikfarjam M., Muralidharan V., Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005, 127(2):208-223.
27. McGahan J.P., Browning P.D., Brock J.M., et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990, 25(3):267-270.
28. Rossi S., Fornari F., Pathies C., et al. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990, 76(1):54-57.
29. Scaife C.L., Ng C.S., Ellis L.M., et al. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol 2006, 13(4):542-546.
30. Mullen J.T., Walsh G.L., Abdalla E.K., et al. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg 2004, 199(5):826-829.
31. Raman S.S., Lu D.S., Vodopich D.J., et al. Minimizing diaphragmatic injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model. Radiology 2002, 222(3):819-823.
32. Laeseke P.F., Sampson L.A., Winter T.C., et al. Use of dextrose 5% in water instead of saline to protect against inadvertent radiofrequency injuries. AJR Am J Roentgenol 2005, 184(3):1026-1027.
33. Laeseke P.F., Sampson L.A., Brace C.L., et al. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am J Roentgenol 2006, 186(Suppl 5):S249-S254.
34. Head H.W., Dodd G.D., Dalrymple N.C., et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 2007, 243(3):877-884.
35. Curley S.A., Izzo F., Delrio P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999, 230(1):1-8.
36. Bowles B.J., Machi J., Limm W.M., et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001, 136(8):864-869.
37. Wong S.L., Edwards M.J., Chao C., et al. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg 2001, 182(6):552-557.
38. Iannitti D.A., Dupuy D.E., Mayo-Smith W.W., et al. Hepatic radiofrequency ablation. Arch Surg 2002, 137(4):422-426. [discussion: 427].
39. Jiang H.C., Liu L.X., Piao D.X., et al. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002, 8(4):624-630.
40. Kosari K., Gomes M., Hunter D., et al. Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg 2002, 6(2):255-263.
41. Kuvshinoff B.W., Ota D.M. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002, 132(4):605-611. [discussion: 611-2].
42. Bleicher R.J., Allegra D.P., Nora D.T., et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003, 10(1):52-58.
43. Scaife C.L., Curley S.A. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 2003, 12(1):243-255.
44. Goldberg S.N. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001, 13(2):129-147.
45. Dodd G.D., Napier D., Schoolfield J.D., et al. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 2005, 185(1):51-57.
46. Wah T.M., Arellano R.S., Gervais D.A., et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005, 237(3):1097-1102.
47. Skonieczki B.D., Wells C., Wasser E.J., et al. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe?. Eur J Radiol 2010, [Epub ahead of print].
48. Wong S.L., Mangu P.B., Choti M.A., et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010, 28(3):493-508.
49. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239(6):818-825. [discussion: 825-7].
50. Berber E., Pelley R., Siperstein A.E. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005, 23(7):1358-1364.
51. Wood T.F., Rose D.M., Chung M., et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000, 7(8):593-600.
52. Machi J., Uchida S., Sumida K., et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001, 5(5):477-489.
53. Chan R.P., Asch M., Kachura J., et al. Radiofrequency ablation of malignant hepatic neoplasms. Can Assoc Radiol J 2002, 53(5):272-278.
54. Eisele R.M., Neumann U., Neuhaus P., et al. Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg 2009, 33(4):804-811.
55. van Vledder M.G., Pawlik T.M., Munireddy S., et al. Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. Ann Surg Oncol 2010, 17(10):2756-2763.
56. Izzo F. Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol 2003, 10(5):491-497.
57. Tabuse K., Katsumi M. Application of a microwave tissue coagulator to hepatic surgery the hemostatic effects on spontaneous rupture of hepatoma and tumor necrosis. Nippon Geka Hokan 1981, 50(4):571-579.
58. Tabuse K., Katsumi M., Kobayashi Y., et al. Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg 1985, 9(1):136-143.
59. Martin R.C., Scoggins C.R., McMasters K.M. Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 2007, 96(6):481-486.
60. Skinner M.G., Iizuka M.N., Kolios M.C., et al. A theoretical comparison of energy sources-microwave, ultrasound and laser-for interstitial thermal therapy. Phys Med Biol 1998, 43(12):3535-3547.
61. Wright A.S., Lee F.T., Mahvi D.M. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003, 10(3):275-283.
62. Martin R.C., Scoggins C.R., McMasters K.M. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 2010, 17(1):171-178.
63. Tanaka K., Shimada H., Nagano Y., et al. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 2006, 139(2):263-273.
64. Muralidharan V., Christophi C. Interstitial laser thermotherapy in the treatment of colorectal liver metastases. J Surg Oncol 2001, 76(1):73-81.
65. Germer C.T., Albrecht D., Roggan A., et al. Technology for in situ ablation by laparoscopic and image-guided interstitial laser hyperthermia. Semin Laparosc Surg 1998, 5(3):195-203.
66. Sturesson C., Liu D.L., Stenram U., et al. Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rat. J Surg Res 1997, 71(1):67-72.
67. Heisterkamp J., van Hillegersberg R., Ijzermans J.N. Interstitial laser coagulation for hepatic tumours. Br J Surg 1999, 86(3):293-304.
68. Vogl T.J., Muller P.K., Hammerstingl R., et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology 1995, 196(1):257-265.
69. Dick E.A., Joarder R., de Jode M., et al. MR-guided laser thermal ablation of primary and secondary liver tumours. Clin Radiol 2003, 58(2):112-120.
70. Dick E.A., Wragg P., Joarder R., et al. Feasibility of abdomino-pelvic T1-weighted real-time thermal mapping of laser ablation. J Magn Reson Imaging 2003, 17(2):197-205.
71. Vogl T.J., Straub R., Eichler K., et al. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 2004, 230(2):450-458.
72. Pech M., Wieners G., Freund T., et al. MR-guided interstitial laser thermotherapy of colorectal liver metastases: efficiency, safety and patient survival. Eur J Med Res 2007, 12(4):161-168.
73. Vogl T.J., Straub R., Eichler K., et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). Radiology 2002, 225(2):367-377.
74. Padma S., Martinie J.B., Iannitti D.A. Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 2009, 100(8):619-634.
75. Kennedy J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005, 5(4):321-327.
76. Jung S.E., Cho S.H., Jang J.H., et al. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom Imaging 2010, [Epub ahead of print].
77. Davalos R.V., Mir I.L., Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005, 33(2):223-231.
78. Miller L., Leor J., Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 2005, 4(6):699-705.
79. Edd J.F., Horowitz L., Davalos R.V., et al. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006, 53(7):1409-1415.
80. Rubinsky B., Onik G., Mikus P. Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat 2007, 6(1):37-48.